DCBN Featured News

DCBN News

• 

  Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancer

  October 24, 2026 Comments Off on Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancer

• 

  IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial

  October 24, 2026 Comments Off on IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial

• 

  Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer

  October 24, 2026 Comments Off on Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer

• 

  Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer

  October 24, 2026 Comments Off on Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer

• 

  Foundation Fighting Blindness Launches First-Ever National VisionWalk Day

  October 23, 2026 Comments Off on Foundation Fighting Blindness Launches First-Ever National VisionWalk Day

• 

  Precisio Biotix Therapeutics Receives Additional Funding to Advance a New Approach to Bacterial Vaginosis (BV), A Major Women’s Health Issue

  October 23, 2026 Comments Off on Precisio Biotix Therapeutics Receives Additional Funding to Advance a New Approach to Bacterial Vaginosis (BV), A Major Women’s Health Issue

• 

  Rishika Kaundal, MD, Introduces Hybrid Choice™ Concierge Program Through Concierge Choice Physicians

  October 23, 2026 Comments Off on Rishika Kaundal, MD, Introduces Hybrid Choice™ Concierge Program Through Concierge Choice Physicians

• 

  FDA grants 510(k) clearance for BoneEnhance, the first machine learning layer on RIVANNA’s Accuro XV platform

  October 22, 2026 Comments Off on FDA grants 510(k) clearance for BoneEnhance, the first machine learning layer on RIVANNA’s Accuro XV platform

• 

  BRG Communications Adds Four Senior Leaders Amid Continued Agency Growth in Healthcare Communications

  October 22, 2026 Comments Off on BRG Communications Adds Four Senior Leaders Amid Continued Agency Growth in Healthcare Communications

• 

  PAK BioSolutions and iBET Advance Integrated Continuous AAV8 Purification

  October 22, 2026 Comments Off on PAK BioSolutions and iBET Advance Integrated Continuous AAV8 Purification